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Abstract 
Background: Assistive devices are currently provided to people with neuro-disabling conditions to 
promote or maintain independence in activities of daily living. However, it is unclear whether 
assessment procedures performed by health care professionals to guide the provision of assistive 
devices are standardized.  
Objective: To explore the assessment and service-delivery processes of assistive devices for people 
with multiple sclerosis, cerebrovascular disease and Parkinson’s disease experiencing physical 
disability by health care professionals in the United Kingdom.  
Methods: A survey was conducted among UK health care professionals working with people with 
neuro-disabling conditions. Descriptive and content analyses were used to code survey data. 
Results: 231 health care professionals completed the survey: 93 occupational therapists, 136 
physiotherapists and 2 assistant practitioners. Less than half of the respondents (46%) reported use 
of local, national, or combined guidelines when assessing a service user’s suitability or need for 
assistive devices. When guidelines were used, they were not consistent and not specifically for 
assistive devices. The respondents stated that when users were allocated small and portable assistive 
devices, they were supplied within four weeks. This period increased for large equipment, major 
home adaptions or if external specialist services and/or funding was needed.  
Conclusions: Standardized operating procedures for assistive device provision are not being carried 
out within the UK. Variable access to assistive devices supplied by the state indicates inequity 
across regions. Future research should explore potential benefits of developing standardized 
assessment procedures for the provision of assistive devices and devise methods to reduce current 
variability in service delivery. 
Keywords: assistive technology, stroke, multiple sclerosis, Parkinson’s disease, guidelines 
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Introduction 
In the Global Burden of Disease study, people with severe impairments resulting from stroke, 
Parkinson’s disease and multiple sclerosis have been associated with higher disability in 
comparison with other neurological conditions.1 These neuro-disabling conditions are also 
associated with neurological symptoms such as tremor, muscle weakness, and balance impairments 
which can affect all aspects of the International Classification of Functioning, Disability and Health 
scale.2 These symptoms can contribute to limitations and severe impairments when engaging in 
functional activities of daily living (ADLs), thereby restricting participation and increasing 
dependence on carers.3 
People experiencing difficulties with ADLs are commonly referred to rehabilitation services, 
including physiotherapy and occupational therapy, to ameliorate functional limitations.4 In many 
cases this involves a needs assessment and the provision of certain assistive technologies. The 
World Health Organization defines assistive devices and technologies as: “those whose primary 
purpose is to maintain or improve an individual’s functioning and independence to facilitate 
participation and enhance overall well-being”.5 Assistive devices aim to address the negative impact 
of a neuro-disabling condition. According to the World Report on Disability, assistive devices 
promote independence and social participation.6 Assistive devices such as grab rails, bath aids, 
hoists, ramps and wheelchairs aim to promote independence during mobility, activities and personal 
care, increase safety, and decrease burden on carers.7,8,9,10,11  
Limitations experienced by people with neuro-disabling conditions can increase over time and 
therefore assistive device provision may require periodic review. A focus group conducted prior to 
this study identified that people with multiple sclerosis with moderate to severe disability 
experienced a range of barriers to the assessment and provision of assistive devices by the National 
Health Service (NHS). These included:long waiting times, a lack of an initial and follow-up 
assessment and a mismatch of the devices provided according to the individual’s needs. In some 
instances, this led to early abandonment of assistive devices. Early abandonment is a well-
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recognized issue 12,13 and one third of assistive technologies provided are subsequently 
abandoned.14,15 
It is crucial to assess and provide assistive technology in a timely manner and ensure that users are 
central to the decision-making process.16 In the current scientific literature, there are two main 
models for the selection of and advisory process for assistive technology. The Human Activity 
Assistive Technology (HAAT) model addresses personal factors including characteristics and 
symptoms of the condition, as well as contextual factors, including the type of social support and 
current state of finances of the person being assessed for assistive technology. 17 This model puts 
emphasis on the evaluation of the assistive devices selection process but has not been tested for 
validity, does not include tools for assessment and does not explore to what extent the use of 
assistive devices continues after they are provided to disabled people.18 The second model, called 
The Matching Person and Technology Model (MPT), facilitates the selection of the most suitable 
AT in relation the consumer's perspectives and abilities, the specifics of the AT and the individual 
environmental conditions. It has been found to be reliable in the United States of America, Canada, 
Australia and Ireland.19 Within the NHS and Social Services, patients with neuro-disabling 
conditions are usually assessed for their needs for assistive devices based on their symptoms and 
likely disease progression, current abilities and environment by health care professionals. However, 
currently unknown to what extent the HAAT, MPT or similar guidelines, are used or preferred by 
health care professionals in the United Kingdom (UK). 
The objectives of this study, therefore, were to explore current assessment practices by UK 
healthcare professionals and subsequent provion and review of assistive devices, for people with 
multiple sclerosis, stroke and Parkinson’s disease experiencing physical disability.  
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Method 
Ethical approval to conduct this research was obtained from the School of Health Sciences Ethics 
Committee, University of East Anglia (reference: 20152016-1). 
Target sample 
A convenience sample of health care professionals with an experience of assistive devices provision 
was approached and asked to participate. Participants needed to be: (i) >18 years old; (ii) currently 
working or having previously worked in in-patient or community settings; currently responsible for 
undertaking assessments for assistive technology; (iii) previously responsible for assessing the need 
for and providing assistive devices for service users. 
Survey development and pre-testing 
An open survey was developed by a team of researchers at the School of Health Sciences, 
University of East Anglia (UEA) and an occupational therapist from the Norfolk and Community 
Health and Care NHS Trust. The survey contained a combination of open- and closed-ended 
questions. These were developed from the issues about the long waiting times for provision and 
assessment process raised by the participants during the focus group. In some instances, Likert-
scales were used for close-ended questions. Survey items were generated in alignment with 
identified themes which emerged from the previous focus group exercise, for example: long waiting 
times for provision and assessment process. In line with the research question, items were 
developed based on measuring the attitudes and opinions of health care professionals about the 
assessment and provision of assistive devices. 20  The survey was made available online using 
Survey Monkey®. The e-survey was piloted by two researchers and two health care professionals 
working with people with neurological conditions.  
The final version contained 13 items that focused on: the participants’ level of experience, the type 
of assistive devices they provide, the duration between assessment and provision, whether they 
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follow clinical guidelines when conducting assessments and whether a follow-up consultation takes 
place. The final version of the survey is presented in the Appendix.  
Recruitment and Data Collection 
As this was a scoping exercise, a snowball sampling was carried out.21 Health care professionals 
were identified and recruited via the research leads of: (1) Royal College of Occupational 
Therapists and (2) Chartered Society of Physiotherapists. In addition, participants were recruited 
from the following specialist interest groups in neurology: (3) Royal College of Occupational 
Therapist Specialist Section- Neurological Practice and (4) Association of Chartered 
Physiotherapists in Neurology. An email invitation was sent to the identified members of the 
organizations with a cover letter which introduced the study and, contained a link to the participant 
information and the e-survey. Data were collected from October 2015 until February 2016. 
Participants were able to review and change their answers on the e-survey. A unique user identifier 
was provided to each participant to avoid duplicate survey entry. 
Data analysis 
Following collection, nominal and ordinal data were downloaded from Survey Monkey® in an Excel 
format then imported into the Statistical Package for the Social Sciences (SPSS Version 19.0, IBM 
Corp, Armonk NY). Descriptive statistics were calculated from all completed entries. Likert scale 
responses were analyzed using percentages calculated by the number of respondents from the total 
sample that responded to each item of the scale. Pivot table analysis was used as a sub-group 
analysis in Excel to explore any trends within UK counties and years of experience of health care 
professionals who use guidelines.22 Responses to open-ended questions were analyzed using 
inductive content analysis,23,24 which involved classification and reduction of data into contextual 
elements.25 This process identified recurring codes by LTT, which were then discussed and 
modified accordingly by LTT and BM.  
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Results 
In total, 231 health care professionals completed the survey: 93/231 (40%) occupational therapists, 
136/231 (59%) physiotherapists and 2/231 (1%) assistant practitioners. The majority of the 
participants 217/231 (94%) worked within the NHS and 14/231 (6%) worked within the Social 
Services. From the respondents, 214 (93%) worked in England, 9 (4%) worked in Scotland, 7 (3%) 
worked in Wales and 1 (<1%) worked in Northern Ireland. The work setting of participants 
included: in-patient 58/231 (25%), out-patient 96/231 (42%), specialist neurology 73/231 (32%) 
and general 4 (2%). The mean level of experience was 11.3(SD: 7.95) years.  
Following assessment, health care professionals provided mainly aids for mobility 216/231 (94%) 
and aids for moving and handling 202/231 (87%) (Figure 1). In addition, 58/231 (25%) provided 
other devices including: bathing and seating equipment, splinting, orthotics, rehabilitation health 
technologies such as Functional Electrical Stimulation, environmental control systems and 
monitoring systems such as telecare, fall and bed sensors. 
More than half of the respondents 124/231 (54%) stated that they do not follow any guidelines 
when assessing for assistive devices. From the participants who use guidelines, 70/104 (67%) use 
local guidelines, 18/104 (2%) use national guidelines, and 16/104 use both local and national 
guidelines. Data from the open questions about the type of guidelines used by the respondents were 
the following: local included local Trust specific a company based (NRS Healthcare) and national 
included (a) OT specifically based such as Royal College of Occupational Therapists (RCOT 
practice guidelines, 2017);26 (b) national: National Institute for Health and Care Excellence for 
multiple sclerosis and Functional Electrical Stimulation;27,28 (c) National Service Framework for 
Long Term Conditions, and Care Act guidelines29 and (d) equipment based such as hoisting 
guidelines. From pivot table analysis, there were not any trends within UK counties and years of 
experience of health care professionals concerning those who use guidelines compared to those who 
do not.  
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Health care professionals stated that people with neuro-disabling conditions were assessed for 
assistive devices: immediately 56/230 (24%), within a week 49/230 (21%), between 1-4 weeks 
63/230 (27%) or between 1-6 months 44/230 (19%) (Figure 2). Assessments for assistive devices 
were reported to be conducted face to face 205/231 (89%), purely via the telephone 1/231 (<1%), or 
face to face and via the telephone 25/231 (10.8%). Once the equipment is installed or provided, 
166/231 (72%) carry out a follow-up consultation. Following assessment, assistive devices were 
provided: immediately 17/231 (7.4%), within a week 101/231 (43.7%), between 1-4 weeks 70/231 
(30.3%), between 1-6 months 22/231 (9.5%), between 6-12 months 1/231 (0.4%), more than a year 
1/231 (0.4%) and did not know 19/231 (8.2%) (Figure 3). 
The main reasons for the long waiting time were: (1) type and size of item- larger items took longer, 
(2) dependent on an external specialist service and (3) dependent on funding and the financial 
situation of the person with the neuro-disabling condition.  
Type and size of item-larger items took longer. The majority of the respondents agreed that if the 
assistive device was readily available from a store, then that item could be provided to the user 
within 24 hours. It was stated that ‘major’ compared to ‘minor’ adaptations to the house, such as 
installing a stair lift, could take up to six months.  
Dependent on an external specialist service. Respondents identified that major adaptations and 
equipment required a lengthy assessment and referral process to an external organization or 
company. This involved evaluating prospective risk, such as an increase in falls, then obtaining a 
completed consent from the user for an assistive device. Health care professionals stated that length 
of waiting time seemed to depend on whether or not the local social services accepted the 
assessment from the NHS. In addition, installation of equipment depended on the availability of 
technicians. The two main organizations, NHS and Social Services, seemed to face challenges when 
working together. Health care professionals working within the NHS stated that major adaptations 
“are a huge issue, as this is social service-led” [P228].  
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Dependent on funding and financial situation of the user. Waiting time also depended on two 
issues: funding bodies and the financial situation of the user. Small equipment, such as hand rails 
and walking sticks, were funded by the NHS or social services using ‘community equipment loan 
stores’. However, more expensive equipment, such as wheelchairs and bath lifts, required an 
application for external funding. The latter had to “be approved by a panel and then sourced” 
[P159]. If the equipment was self-funded by the patient, the waiting time was less.  
Discussion 
This study has given rise to new knowledge about current routine practice for the assessment and 
provision of assistive devices for people with neuro-disabling conditions. The results from the 
survey showed that less than half of the respondents used guidelines during the assessment process. 
It appears that a standardized practice for assistive device provision is not being applied routinely 
within the UK. Delays between assessment and provision of assistive devices depended on the size 
of the equipment, the scale of adaptations required for installation, coordination of multiple service 
providers and source of funding.  
Generally, there is not a tendency for standardized guidelines to be used during assessment and 
provision of assistive devices in the UK. In a similar survey, only 20% of health care professionals 
used guidance with users when measuring home assistive devices.30 Clinical guidelines should be 
based on evidence-based recommendations.31 One reason for the lack of use could be due to the 
limited high-quality evidence-based procedures for AT selection in neurological settings.19 As a 
result, the health care professionals reported that they do not use guidelines consistently when 
performing assessment procedures for assistive devices. Lack of alignment of protocol use could be 
the reasons for the delay in the provision of assistive devices and home adaptations.31 These delays 
can cause patient and carer strain and increase disease symptoms and functional limitations.32,33,34  
In the present study, it was reported that more than a quarter of the health care professionals do not 
carry out a follow-up assessment of the assistive devices provided. This could be a contributory 
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factor as to why 28.6 to 50% of mobility assistive devices are currently abandoned in the stroke 
population.35 Thus, ensuring that the assistive device fits the lifestyle and needs of the patient 
should be compulsory and follow-up should be addressed when developing future guidelines which 
could decrease abandonment.14 This could limit waste of funds spent by national health systems.  
This is the first survey exploring the topic of assistive device provision with a large sample of 
health care professionals in the UK. However, limitations should also be acknowledged. 
Recruitment of a large number of health care professionals from social services would have 
improved the sample representativeness. Due to the use of a snowball sampling technique, we did 
not know the exact number of potential participants asked to complete the survey. Respondents 
were not selected in a random order and, therefore, the open question responses could have been 
biased towards expressing views of people who had a negative experience from assistive device 
services. In addition, the respondents worked with different neuro-disabling conditions and, 
therefore, the results may not be generalizable to a particular condition such as stroke. Finally, in 
order to adhere to the minimal time needed for survey completion, the age and type of gender were 
not included as items in the survey and, therefore, socio-demographic information about the 
respondents is minimal. 
Future Research 
Clinical guidelines have the potential to improve quality of care and improve outcome.36,37 
Additionally, using standardized clinical guidelines has implications for increased efficiency of 
assistive device provision and optimizing value of money in health and social care provision.38 
When an assistive device implementation and evaluation protocol was implemented for 54 people 
with multiple sclerosis in Italy, this resulted in a significant decrease in device abandonment.12 
However, this is a small study involving only one neuro-disabling condition.  
The next step for future research should explore the development and implementation of a user-led, 
standardized guideline for assistive devices. This should involve input from a large sample of 
people with neuro-disabling conditions as well as health care professionals who have expertise in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
  10 
the use and prescription of assistive devices. Guideline development expertise and endorsement for 
the final document should also be sought from the professional bodies who should be involved in 
the project from the outset. Moreover, it  would be important to evaluate the level of abandonment 
and satisfaction of the client and carers once implemented within the UK.49 Due to the fact that 
there is a broad range of assistive devices, specific guidelines for the sub-groups of assistive devices 
(such as walking aids, manual handling equipment) should also be considered, to promote a client-
centered approach. Such guidelines should incorporate the evaluation of the needs and suitability of 
the personal and contextual individual factors.11 Additionally, appropriate outcome measures such 
as the Quebec User Evaluation of Satisfaction with Assistive Technology,40 the Carer Asssistive 
Technology Outcome Measure,41 or the Psychsocial Impact of Assistive Devices Scales42 should be 
used at immediate and long-term follow-up assessments to assess the effectiveness of any 
implementations.43,44,45 
Conclusion 
This study has provided some knowledge of the current practice used for the assessment and 
provision of assistive devices for people with neuro-disabling conditions by health care 
professionals in UK. The delay in the provision of assistive devices depended on the size of the 
item, the size of the adaptations needed for the installation of assistive devices, lack of coordination 
between services and funding. Results showed that health care professionals do not follow a 
consistent standardized procedure for service delivery of assistive devices. Therefore, future 
research should explore the development and implementation of standardized guidelines to be used 
by all Trusts and services in the UK. This could potentially enable effective assessment of 
suitability and provision of assistive devices and ensure that people with neuro-disabling conditions 
get the equipment they need to live as independently as possible. 
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Figure Captions 
 
Figure 1: Type of assistive devices (%) provided to people with neuro-disabling conditions after 
assessment by health care professionals 
Figure 2: Showing percentage waiting time by person with neuro-disabling condition for an 
assessment by the health care professional 
 
Figure 3: Showing percentage waiting time by person with neuro-disabling condition for the 
assistive device to be provided 
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Appendix- Survey questions 
Please could you tell us: 
 
1) What is your profession? 
 
Occupational Therapist  
Physiotherapist  
 
Assistant Practitioner  
 
Other  ___________________________ 
 
 
2) In which county of United Kingdom do you work? 
 
 
3) Where do you work? 
 
National Health Service  
 
Social Services  
 
4) What is your work setting? 
 
Inpatient  
 
Community  
 
Specialist Neurology  
 
General  
 
5) How long have you been working with people with neurological conditions? 
 
 
6) Following assessments which devices have you recommended/provided? (tick all 
that apply) 
 
Small aids (e.g. grab rails)  
 
Toileting aids (e.g. commodes)  
 
Aids for activities of daily living (e.g. adapted cutlery)  
 
Aids for mobility (e.g. walking aids, wheel-chairs)  
 
Aids for moving and handling (e.g. hoists)  
 
Aids for access (e.g. ramps, stair lifts)  
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7) In your experience of carrying out the assessment for assistive devices, do you 
follow any guidelines? 
 
Yes  Provide name of guidelines: ________________________ 
 
No   
 
8) If you answered yes, are the guidelines: 
 
Local  
 
National  
 
9) In your experience, on average how long do patients need to wait for the 
assessment for assistive devices carried out by the professional? 
 
No waiting time                    
 
Within a week                    
 
Between 1-4 weeks                 
 
Over a month                     
 
Over 6 months                  
 
More than a year              
 
I don’t know  
 
10) How are assessments for assistive devices carried out? (tick all that apply) 
 
Face-to-face  
 
Telephone  
 
11) Post-assessment, generally how long do patients wait for the equipment to be 
provided? 
 
No waiting time                    
 
Within a week                    
 
Between 1-4 weeks                 
 
Over a month                     
 
Over 6 months                  
 
More than a year              
 
I don’t know  
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12) Once the equipment is installed and provided, do you carry out a follow-up visit? 
 
Yes  
 
No  
 
13) Once the equipment is installed and provided, do you carry out a follow-up phone 
call? 
 
Yes  
 
No  
 
 
 
Thank you for completing this survey. 
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